| Dr John J Napierkowski, MD | |
|
280 Exempla Cir, Lafayette, CO 80026-3370 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr John J Napierkowski |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 28 Years |
| Location | 280 Exempla Cir, Lafayette, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801877683 | NPI | - | NPPES |
| 43389261 | Medicaid | CO | |
| 019007 | Other | CO | KAISER COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 99-94 (New Mexico) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 46539 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
News Archive
With strong consumer interest in probiotics-and new manufacturer innovations for incorporating these ingredients into a broader array of food products-new standards to help ensure the quality of probiotic food ingredients are being proposed for public review and comment.
NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses which go inside the eye, today announced two strategically important regulatory approvals.
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
› Verified 5 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
With strong consumer interest in probiotics-and new manufacturer innovations for incorporating these ingredients into a broader array of food products-new standards to help ensure the quality of probiotic food ingredients are being proposed for public review and comment.
NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses which go inside the eye, today announced two strategically important regulatory approvals.
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John J Napierkowski, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr John J Napierkowski, MD 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 338-4545 |
News Archive
With strong consumer interest in probiotics-and new manufacturer innovations for incorporating these ingredients into a broader array of food products-new standards to help ensure the quality of probiotic food ingredients are being proposed for public review and comment.
NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses which go inside the eye, today announced two strategically important regulatory approvals.
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
› Verified 5 days ago
Dr. Samer K Khodor, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-6450 | |
Dr. Heather A Raff, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Cristina Fernandez Conklin, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Amy N Duckro, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Austin J Lammers, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-724-6031 | |
Laurence J Connors, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Michael Richard Benoit, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 967 Stagecoach Dr, Lafayette, CO 80026 Phone: 405-408-9008 |